David J Julian, MD | |
1900 W 4th St, Mt Vernon, IN 47620 | |
(812) 838-2231 | |
(812) 838-4628 |
Full Name | David J Julian |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 1900 W 4th St, Mt Vernon, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629038724 | NPI | - | NPPES |
100210120A | Medicaid | IN | |
000000042339 | Other | IN | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 61625379A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
David J Julian, MD 1900 W 4th St, Mt Vernon, IN 47620 Ph: (812) 838-2231 | David J Julian, MD 1900 W 4th St, Mt Vernon, IN 47620 Ph: (812) 838-2231 |
News Archive
Pseudomonas aeruginosa is a dangerous bacterium that causes infections in hospital settings and in people with weakened immune systems. It can cause blood infections and pneumonia, while severe infections can be deadly.
Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition.
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
National Paracycling Champion Tom Staniford has an extremely rare condition which, until now, has puzzled his doctors. He is unable to store fat under his skin - yet has type 2 diabetes - and suffered hearing loss as a child. Now, thanks to advances in genome sequencing, an international research team led by the University of Exeter Medical School has identified Tom's condition and pinpointed the single genetic mutation that causes it.
› Verified 5 days ago